The synthesis and characterisation of a partially substituted calix [4]arene, namely, 5,11,17,23-tetra-tertbutyl,25,27-bis[aminoethoxy] 26,28-dihydroxycalix[4]arene are reported. Its interaction with commonly used pharmaceuticals (clofibric acid, diclofenac and aspirin) was investigated by spectroscopic ( 1 H NMR and UV), electrochemical (conductance measurements) and thermal (titration calorimetry) techniques. It is concluded on the basis of the experimental work and molecular simulation studies that the receptor interacts selectively with these drugs. Preliminary studies on the selective extraction of these pharmaceuticals from water by the calix receptor are reported and the potential for a carrier mediated sensor based on this ligand for 'on site' monitoring of pharmaceuticals is discussed.
Introduction
In the last few years contamination of water by pharmaceuticals has become a serious concern by environmental scientists (Daughton and Ternes, 1999; Sorenson et al., 1998; Ternes et al., 1999) . Pharmaceuticals can enter the aquatic environment through many sources resulting from their use for the treatment of humans and animals and can be excreted unchanged, as metabolites, as unused discharge or as residuals of drug manufacturers (Heberer, 2002; Winkler et al., 2001; Stumpf et al., 1999) .
Several methods have been reported for the removal of pharmaceuticals from water such as metal salt coagulation and excess lime/soda ash softening (no significant removal), (Adams et al., 2002; Ternes et al., 2002; Boyd et al., 2003) powdered activated carbon (slow kinetics of sorption (Boyd et al., 2003; Westerhoff et al., 2005) , material becomes saturated over time, non-selective (Boyd et al., 2003; Westerhoff et al., 2005) ). Chlorination (by products formed (Boyd et al., 2003; Westerhoff et al., 2005) of unknown toxicity, removal rate is pH dependent which could not be controlled in a treatment plant environment (Pinkston and Sedlak, 2004) ), ozonation (Huber et al., 2003; Huber et al., 2005; Ternes et al., 2003) (oxidation by ozone is effective to remove most pharmaceuticals from water but the toxicity of ozone and byproducts resulting from this process has adverse implications on human health and the environment), UV photolysis (Up to 80% removal only with very high input of 3000 mJ cm . Inefficient (Heberer, 2002) ), ion exchange (non-selective), reverse osmosis (90% of pharmaceuticals are removed but it is expensive (Heberer, 2002) ).
Diclofenac {2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid} is a non-steroidal anti-inflammatory drug currently used to treat painful conditions resulting from arthritis, sprains and strains, gout, migraine, and other illnesses. Clofibric acid [2-(4-chlorophenoxy)-2-methylpropanoic acid] is known as the active metabolite of a number of drugs currently used to reduce the levels of cholesterol in blood. Aspirin (acetyl salicylic acid) is one of the most frequently used drugs, it is an analgesic with pain relief and anti-inflammatory properties (Albert, 2010) . In small doses, aspirin is recommended to reduce the risks of heart attacks, angina and strokes (Mundasad, 2016; Lewis et al., 1983) . Side effects of this drug have been reported (Gorelick, 2009 ). These pharmaceuticals are widely detected in the environment (Nikolaou et al., 2007) . As far as diclofenac is concerned, methodologies used for its removal from water include electron beam radiation combined with a biological aerated filter (Dal et al., 2011) , pyrite catalysed Fenton oxidation (He et al., 2014) , double templates-molecularly imprinted polymers (Bae et al., 2013) , cork-based activated carbon (Dai et al., 2013) , poly-ethylenimine-modified chitosan beads (Mestre et al., 2010) , membrane bioreactors (Tambozi et al., 2010) , and modified clays (Dordio et al., 2009) . In deriving the Margin of Exposure (MOE) of pharmaceuticals, calculated guideline values were based on comparisons made with maximum concentrations found in secondary treated effluents. It was then assumed that values in drinking water are likely to be lower and therefore their presence may not lead to a negative impact on human health (Anon, 2012) . This may be the case for highly developed Countries but not necessarily for the Developing World where often water treatments are not always applied.
Therefore, the threshold of toxicological effects due to the presence of pharmaceuticals in water needs further research. Another issue to be addressed is the need for establishing standard protocols for sampling and monitoring pharmaceuticals in water. Advanced monitoring techniques such as gas chromatography-mass spectrometry (GC-MS), ion chromatography-mass spectrometry (IC-MS) and others have been used to detect trace amounts of these compounds. Again these techniques are not always available and all of them require the transport of samples from the site to the laboratory. Therefore, efforts are required for 'on site' monitoring of pharmaceuticals in water.
In technologies and monitoring devices aiming for the removal/detection of pollutants from/in contaminated sources it is imperative to introduce the concept of selectivity (ability of the decontaminating agent to recognise one species relative to others), often confused with specificity (recognition of only one particular target while discriminating against others). Selectivity is one of the main features of Supramolecular Chemistry (Cabrera-Lafaurie et al., 2012) and therefore it is surprising to find that this field has not been explored for the removal/monitoring of pharmaceuticals from/in water. Calix [4] arenes (products of the condensation reaction of p-substituted phenol and formaldehyde in basic medium) are versatile receptors (Gutsche, 1989; Gutsche, 2001 Gutsche, , 2007 Mandolini and Ungaro, 2000) . These receptors can be easily modified through the lower and upper rims and a number of derivatives are known to interact with ionic (through the hydrophilic cavity) and neutral (through the hydrophobic cavity situated between the phenyl rings) species (Danil de Namor et al., 1998 . The importance of fundamental studies in searching for applications is a relevant issue to address in the design of monitoring systems for the detection of pollutants as well as for the development of novel technologies for their removal from contaminated sources and most reports in the literature indicate that this is not often the case.
In this paper we report an investigation involving a calix[4]amine derivative, 1, and its interaction with currently used pharmaceuticals, namely diclofenac, aspirin and clofibric acid (Fig. 1) . The selection of the amine functionality in the structure of 1 is based on its great affinity for the proton.
Thus fundamental studies using a variety of techniques (spectroscopic, electrochemical and thermodynamic) involving this receptor and these pharmaceuticals are explored to assess the selectivity of 1 for these pharmaceuticals as the basis for environmental applications.
Experimental
The synthesis of 1 was carried out according to the following Scheme,
The procedure applied by Danil de Namor and Shehab (Shehab, 2005) for the synthesis of calix[4]pyrrole derivatives was adapted for the preparation of L1 and 1 (Scheme 1). A solution of L1 (9 g, 21.45 mmol) was dissolved in dry THF (Scientific, HPLC grade, 99.99%, 100 ml) and stirred in an ice bath until the temperature reached 0°C, LiAlH 4 (95%, Sigma-Aldrich, 1.896 g, 49.95 mmol) was dissolved in freshly dried THF then added drop-wise to the reaction mixture with continuous stirring for 4 h and the temperature was kept at 0°C. The reaction was monitored using TLC and a hexane:ethyl acetate (8:2) mixture as the developing solvent, (10 ml, 20%). Then an aqueous solution of NaOH was added, followed by distilled water (10 ml). A white precipitate was obtained. The undesired white precipitate was filtered gravitationally and the solvent was evaporated by using a rotary evaporator. A white solid was obtained and dried under vacuum at 90°C. The product obtained in 60% yield was characterised by 1 H NMR spectroscopy, (500 MHz, in CDCl 3 ), δ (ppm), 7.03 (s, Ar-H, 4H), 6.96 (s, Ar-H, 4H), 5.2 (s, OH, 2H), 4.34 (d, Ar-CH 2ax -Ar, 4H), 4.06 (t, OCH 2 , 4H), 3.37 (d, Ar-CH 2eq -Ar, 4H), 3.3 (t,N-CH 2 ), 1.2 (s, CH 3 , 18H),1.09(s,CH 3 ,18H).
NMR measurements
1 H NMR measurements were carried out at 298 K using a Bruker AC-500 MHz.
1 H NMR titrations were carried out by adding increasing amounts of known concentrations of the pharmaceuticals (diclofenac, aspirin and clofibric acid, all from Aldrich) dissolved in CD 3 CN (Cambridge Isotope Laboratories, 99.8%) to the NMR tube containing a known concentration of the receptor in the same deuterated solvent. Chemical shift changes of the receptor after each addition of the drug were recorded. Subtracting the chemical shifts for the free receptor δ r from those of the complex, δ C , the chemical shift changes Δδ were calculated from Eq. (1)
Conductometric measurements
The conductivity cell constant was determined according to the method described by Jones and Bradshaw (1933) as previously reported (Danil de Namor et al., 2002) .
Conductometric titrations were carried out by the gradual addition of the receptor solution in acetonitrile to the conductivity cell containing the targeted guest in the same solvent at 298.15 K. For these measurements, the conductivity cell connected to a thermostated water bath and loaded with the guest solution in acetonitrile (25 ml). Then the electrodes were immersed into the cell containing the solution under continuous stirring during the course of the titration. Accurate aliquots of the receptor were gradually added to the guest solution in the same solvent, the resistance was recorded after each addition. The molar conductance, Λ m (S cm 2 mol −1 ) was calculated.
UV measurements
UV-visible spectrophotometric measurements were taken on a Cecil CE7200 spectrophotometer. UV-Vis spectra were recorded in the 200-400 nm range using 1 cm quartz cell to find the wavelength of maximum absorption. For the spectrophotometric titrations, aliquots of a solution of 1 in acetonitrile were added to the UV cell containing a solution of the targeted drug in the same solvent.
Calorimetric measurements
The reliability of the isothermal calorimeter (ITC) was checked by carrying out the standard reaction between Ba (II) and 18-crown-6 in water at 298.15 K suggested in the literature (Briggner and Wadsӧ, 1991) 18C6
The Nano-ITC measurements were carried out in degassed acetonitrile at 298.15 K. For assessing complex formation, a solution of 1 (1 mM) in acetonitrile was placed in the calorimetric cell (1.8 cm 3 ). Solutions of each guest (20 mM) in the same solvent were added (5 or 10 μL) successively into the host solution in the same solvent with a 300 s interval between each injection. Corrections for the heat of dilution were applied. The Nano ITC is connected to a personal computer that included the software ITCRun which follows the information and the status of the reaction taking place.
Molecular modelling
Modelling was carried out using MOE 2015.10 (MOE, 2016). Models were built using the BUILDER module and energy minimised with the MMFF94X force field (Halgren, 1996) . A distance dependent van der Waals cut-off was used of 8 Å (below this distance atoms were treated normally) and van der Waals interactions were discounted after 10 Å. A dielectric constant of 1 was used for atoms below the lower cut-off distance and a value of 80 was used above. Minimisation was carried out using the smart minimiser that combines the steepest descents, conjugate gradients and Newton-Raphson methods as appropriate. Minimisation was carried out to a convergence criterion of 0.0042 RMS (kJ/mol/Å 2 )
Extraction of pharmaceuticals from water
Preliminary experiments to assess the effect of the mass of the receptor, pH and temperature as well as the kinetics of the extraction process were carried out as previously described (Danil de Namor and Khalife, 2008) . Aliquots were taken and analysed by UV spectrophotometry at 280 nm. The uptake capacity of 1 was determined in batch experiments using a constant amount of the receptor (0.1 g) and aqueous solutions containing different concentrations of the pharmaceutical (9.10 ). The tubes containing the mixture were then placed in a water bath and the temperature was maintained at 298 K. Samples were left overnight to equilibrate and then analysed by UV spectrophotometry. The uptake capacity, q eq (mmol g −1 ), was calculated using eq.
In Eq. (3), V denotes the sample volume (cm 3 ), c i and c eq are the initial and the equilibrium concentrations (mmol/dm 3 ) respectively, m is the amount of the receptor used.
Results and discussion

Interaction of 1 with pharmaceuticals
Several analytical techniques were used to assess the interaction of 1 with aspirin, clofibric acid and diclofenac in acetonitrile such as 1 H NMR, conductance, UV spectrophotometry and titration calorimetry. The lack of solubility of the receptor in water led us to select acetonitrile as the solvent. A further advantage of the use of this solvent is that the drugs are unlikely to be well solvated in this medium. In this way solvent-receptor competition for the drug decreases substantially and consequently the strength of guest-receptor interactions increases as previously discussed by Danil de Namor et al. (1998) .
As far as the 1 H NMR measurements are concerned, the results in CD 3 CN listed in Table 1 show the chemical shifts of the free receptor, δ, and the chemical shift changes, Δδ, for the receptor upon the addition Scheme 1. Synthetic procedure used for the preparation of L1 and 1.
of the pharmaceutical. No chemical shifts changes were found by the addition of other drugs containing carboxylic functionalities such as ciprofloxacin (antibiotic used against a wide range of bacterial infections) (Owso-Ababio et al., 1995) , aurintricarboxylic acid (inhibitor of RNA enzymes) (Hallic et al., 1977) , nalidixic acid (Ryan et al., 2011) and ibuprofen (anti-inflammatory drug) (Anon, 2015) . As far as the free receptor is concerned, quite clearly 1 adopts a quasi perfect 'cone' conformation in solution as reflected in the difference observed in the chemical shifts of the axial and equatorial protons (Δδ ax-eq = 1.03 ppm) (Gutsche, 1995) . This conformation is due to the presence of hydrogen bond formation between the phenolic hydrogen and the ethereal oxygen of the pendant arms of the receptor. It was previously demonstrated (Danil de Namor et al., 2002) for an homologous receptor, namely 5,11,17,23-tetrakis-[(diethylamine) ethoxy]calix [4] arene, in the solid state (X ray diffraction studies) and in solution. That the Δδ ax-eq = 1.02 ppm in CD 3 CN for this homologous receptor is practically the same as that for 1. Furthermore acetonitrile was found in the hydrophobic cavity of the receptor. Also the X ray structure of 2 showed acetonitrile in the hydrophobic cavity of the receptor. Previous studies from our group in this solvent demonstrated that this process is also observed in solution (Danil de Namor et al., 1998 . In fact, this is also the case for 1 as assessed from the chemical shift changes observed for the aromatic protons of this receptor in moving from CDCl 3 to CD 3 CN where downfield chemical shifts of 0.21 and 0.19 ppm are observed.
Further conformational changes are also observed in the bridging methylene protons during the complexation or protonation process The equatorial protons become less shielded relative to the free receptor particularly for clofibric acid and diclofenac (− 0.21 ppm) while for aspirin this effect is less pronounced (− 0.11 ppm) while the equatorial protons are slightly deshielded relative to the uncomplexed receptor. A direct consequence of that, is a decrease in the shift difference between each pair of doublets of the ArCH 2 Ar system, from the free to the complex ligands (from 1.03 to 0.76 ppm for aspirin and to 0.66 ppm for clofibric acid and diclofenac). Significant downfield chemical shift changes are observed for H-7, H-8 and the NH proton as a result of an interaction between the amino group of the receptor and the proton of the carboxylic functional group of the drug. The most significant chemical shift changes are found for the NH proton. In an attempt to explain the differences observed in the Δδ values for the NH proton for these pharmaceuticals (Table 1) diclofenac respectively) due to the unavailability of these data in acetonitrile. Although the absolute pK a values of these drugs in the latter solvent are expected to differ significantly from those in water due to the medium effect, the order would be the same. It is therefore concluded that the downfield shift of the NH proton of 1 is strongly dependent of the degree of dissociation of the acid. This is further corroborated by i) 1 H NMR titrations carried out in CD 3 CN. Representative examples for the titration of 1 with clofibric acid (a) and diclofenac (b) are given in Fig. 2 where Δδ values obtained by the addition of these drugs to 1 are plotted against the drug/ 1 M ratio where the most pronounced chemical shift changes are observed for the NH protons and to a lesser extent for H-7 and H-8.
ii) The lack of interaction with other drugs tested given that these behave as relatively weak acids in water as reflected in their pK a values which are 6.09, 6.1 and 4.54 respectively for cyprofloxacin (Torniainen and Int, 1996) ,nalidixic acid (Timmers and Stemglanz, 1978) and ibuprofen (Meloun et al., 2007) and are expected to be undissociated in acetonitrile Therefore we proceeded with conductometric titrations which as previously demonstrated (Danil de Namor et al., 1998) information on the composition of the complex as well as identifying whether the receptor-drug interaction is the result of hydrogen bond formation or a proton transfer reaction (from the pharmaceutical to the calixarene amine derivative) or both. To ensure that the receptor was not protonated its conductance was measured in MeCN prior to proceeding with the titrations. No conductance was observed. However the conductometric curves for the titration of these drugs with the receptor in acetonitrile provide a great deal of information. Fig.  3 shows the titration of clofibric acid (a), diclofenac (b) and aspirin (c) with 1 in MeCN and at 298,15 K where the molar conductances, Λ m (S·cm 2 ·mol − 1 ) are plotted against the 1:drug concentration ratios. The conductometric titration curve for aspirin was found to show hardly any curvature to define the composition of the interaction with this drug and therefore a UV titration was carried out. As shown in Fig.  4 , a complex of 1:1 stoichiometry is formed between this drug and 1.
Interpretation of these data shows that:
i. Prior to the addition of the receptor, the drugs are highly associated in this solvent as reflected by the low conductance observed even at low concentrations. ii. Upon addition of 1, a significant increase in conductance is observed which must be attributed to a proton transfer reaction from the drug to the amine functional group of the receptor iii. The composition of the complex appears to be 1:1 for aspirin which differs from those for clofibric acid and diclofenac where two slight breaks are found in the conductometric titration curves at concentrations ratios of 0.5 and 1 which appear to indicate the formation of 1:2 (A to B) and 1:1 (B to C) complexes .
Having characterised the sites of interaction of the receptor and the composition of the complexes in MeCN at 298 K, we proceeded with the determination of the thermodynamic parameters in this solvent using isothermal titration calorimetry (ITC)·These are now reported in Table  2 where the stability constants (expressed as log K s ), the standard enthalpy, Δ c H°and entropy, Δ c S°for the interaction with aspirin, clofibric acid and diclofenac in acetonitrile at 298.15 K are listed in this Table. The standard deviation of the data is also included.
The data for aspirin fits into a 1:1 (host: guest) complex while those for clofibric acid and diclofenac into 1:2 complexes. As previously stated thermodynamics does not provide structural information. However, it is indisputable that any model proposed must fit the experimental data. Therefore, the thermodynamic data are referred to the following processes, For 1:1 complexes of aspirin, clofibric acid and diclofenac, Eq. (4) is representative of the process taking place in solution on the results obtained from conductance data that these pharmaceuticals predominantly exist as ion pairs in acetonitrile.
RCOOH MeCN
For 1:2 complexes of clofibric acid and diclofenac.
For aspirin the process is enthalpy controlled. The same applies for the 1:1 complexes of clofibric acid and diclofenac. However the formation of 1:2 complexes is enthalpically unfavoured and entropically controlled. These results are striking and suggest that a great disorder in the structure of the receptor occurs to allow the entrance of the second proton. X-ray crystallographic studies of an analogous receptor, 2, with perchloric acid (Villanueva Salas, 2005) has shown the double protonation of the receptor as well as the loss of the solvent upon protonation while the hydrogen bond between the ethereal oxygen and the phenolic oxygen still remains. The conformational change that 1 undergoes in moving from the free to the protonated ligand as shown by 1 H NMR studies in CD 3 CN indicates a flattened 'cone' conformation for the latter relative to the quasi 'cone' conformation of the former and as a result the hydrophobic cavity is able to lose the solvent. This process will lead to an increase in entropy. Given that energy would be required to remove the solvent from the cavity, the process would be enthalpically unfavoured. This interpretation is corroborated by the data reported in Table 2 . Comparison of the protonation constants of 1 with clofibric acid and diclofenac in acetonitrile at 298.15 K relative to those for 2 and HClO 4 in the same solvent and temperature (log K s1 = 15.68, log K s2 = 14.36) demonstrates the effect of the strength of the acid on the protonation process as well as the basic nature of the amine moieties in the pendant arms given that the basicity of the tertiary amine in 2 is higher than that of 1 (primary amine). However the most interesting finding of this research is that this receptor besides having a higher capacity for clofibric acid and diclofenac relative to aspirin is able to recognise selectively these drug to the extent that in terms of a 1:1 receptor: drug interaction 1 is more selective for clofibric acid relative to diclofenac and aspirin by factors of 32 and 2399 respectively in acetonitrile while the overall selectivity of the receptor for clofibric acid with respect to diclofenac is greater by a factor of 316. In order to get further insight regarding the different hosting capacity of 1 for aspirin relative to clofibric acid and diclofenac, molecular simulation calculations were carried out. The outcome is shown in Fig. 5 where the presence of a carbonyl oxygen in the ortho position with respect to the carboxylic group in aspirin leads to two contact points involving the amine functionalities in each of the pendant arms of the receptor. Thus a proton transfer reaction occurs where one of the amino functionalities is protonated (as shown from conductance measurements) while the remaining one enters hydrogen bond formation with the carbonyl oxygen of the ester group of aspirin. It seems that the presence of acetonitrile in the hydrophobic cavity of the ligand preorganise the receptor to interact with the drug. For clofibric acid and diclofenac each amino group of the receptor is protonated by two units of drug.
Preliminary extraction studies of drugs by the calix[4]arene receptor and scope for the design of sensing devices
Given that 1 is a non-soluble receptor in water and to avoid the use of organic solvents which are environmentally unfriendly, preliminary batch experiments on solid-aqueous solution extractions using these pharmaceuticals were carried out. The results so far obtained showed that this receptor is able to remove 82 ± 2 and 71 ± 2% of clofibric acid and diclofenac respectively from water (optimum pH range = 7-8) while the % E was found to be very low for aspirin. It should be emphasised that although it was shown that aspirin interacts with 1 in acetonitrile , it is well established that the solvation properties of this solvent are very poor relative to water. In the latter solvent the Fig. 4 . UV titration of aspirin with 1 in acetonitrile at 298 K. drug is bound to be strongly hydrated and therefore a high competition between the solvent and the receptor for the drug occurs. As the drug is comfortable in water it is reluctant to interact with the receptor, reducing its capacity to remove the drug from water. The trend observed is in accord with that observed for the stability constant data obtained from thermodynamics (Table 2 ) and the pK a values discussed above. Again the capacity values obtained (mmol of drug/g of material), follows the same trend with values of 0.20 and 0.035 mmol/g for clofibric acid and diclofenac respectively. The extraction process was found to be fast (10 min). No changes in the capacity of the receptor were found with temperature, this is expected given that it would depend on the number of sites in the material Recycling of the material can be carried out via a pH switching mechanism Indeed hardly any % E is found at pH 2 due to the protonation of the receptor.
We have recently reported (Danil de Namor et al., 2016) the following correlation for a carrier mediated mercury (II) ion selective electrode
In Eq. (6), K s denotes the stability constant of the receptor and the appropriate metal cation and k is the selectivity coefficient of the metal cation relative to Hg(II). This correlation demonstrated for the first time that selectivity could be established through solution screening (thermodynamics) without having to construct an electrode each time. Further investigations will be carried out to develop a carrier mediated electrode based on 1 and to assess whether Eq.6 is applicable to the systems reported in this paper.
Conclusions
From the above discussion it follows that:
i) The calix[4]arene receptor is able to recognise selectively clofibric acid, diclofenac and aspirin and discriminates against other drugs containing carboxylic functional groups (cyprofloxacin, nalidixic acid and ibuprofen). The interaction is controlled by the dissociation constants of the acids ii) The hosting ability of the receptor is greater for clofibric acid and diclofenac given that two protons are taken up per unit of receptor. For aspirin only one proton is transferred to the receptor. Molecular simulation studies suggest that for the latter drug, one of the amino functionalities is protonated while the remaining one enters hydrogen bond formation with the carbonyl oxygen of the ester group of aspirin. iii) Thermodynamics provides a quantitative assessment of the strength of interaction through the stability constant. The availability of enthalpy and entropy data allows to assess whether the process is enthalpy or entropically controlled. iv) Preliminary extraction data are encouraging as far as the use of this receptor for the selective removal of these drugs from water
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